guest ::
| Home > Institute Collections > W500 > Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity. |
| Home > Institute Collections > W500 > Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity. |
| Journal Article | DKFZ-2025-02385 |
; ; ; ; ; ; ; ; ; ; ; ; ; ;
2021
Springer Nature
[London]
Abstract: IL-2 is the master-regulator cytokine for T cell dependent responses and is crucial for proliferation and survival of T cells. However, IL-2-based treatments remained marginal, in part due to short half-life. Thus, we aimed to extend IL-2 half-life by flanking the IL-2 core with sequences derived from the extensively glycosylated hinge region of the NCR2 receptor. We termed this modified IL-2: 'S2A'. Importantly, S2A blood half-life was extended 14-fold compared to the clinical grade IL-2, Proleukin. Low doses inoculation of S2A significantly enhanced induction of Tregs (CD4+ Regulatory T cells) in vivo, as compared to Proleukin, while both S2A and Proleukin induced low levels of CD8+ T cells. In a B16 metastatic melanoma model, S2A treatment was unable to reduce the metastatic capacity of B16 melanoma, while enhancing induction and recruitment of Tregs, compared to Proleukin. Conversely, in two autoimmune models, rheumatoid arthritis and DSS-induced colitis, S2A treatment significantly reduced the progression of disease compared to Proleukin. Our results suggest new avenues for generating long-acting IL-2 for long-standing treatment and a new technique for manipulating short-life proteins for clinical and research uses.
Keyword(s): Animals (MeSH) ; Arthritis, Rheumatoid: prevention & control (MeSH) ; Autoimmunity: drug effects (MeSH) ; Delayed-Action Preparations (MeSH) ; Drug Evaluation, Preclinical (MeSH) ; Glycosylation (MeSH) ; Half-Life (MeSH) ; Interleukin-2: administration & dosage (MeSH) ; Interleukin-2: analogs & derivatives (MeSH) ; Interleukin-2: pharmacokinetics (MeSH) ; Mice, Inbred C57BL (MeSH) ; Mice, Knockout (MeSH) ; Natural Cytotoxicity Triggering Receptor 2: chemistry (MeSH) ; T-Lymphocytes, Regulatory: drug effects (MeSH) ; Mice (MeSH) ; Delayed-Action Preparations ; Interleukin-2 ; Natural Cytotoxicity Triggering Receptor 2
; 
; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record
|
The record appears in these collections: |
